Ajanta-Pharma Stock/Share Prices, Buy and Sell Ajanta-Pharma BSE Stocks

Ajanta Pharma Ltd NSE / BSE
Pharmaceuticals, Large Cap

Invest

22 Jan 2019 | 03:59 PM

1,162.70

19.45 (1.70%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-25.73%

Return (1Y)

Underperformed S&P BSE Healthcare by 19.3%
More Volatile

2.2%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 1.07%
Consistent Performer

7/12

Months

beaten S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

1,592

898

News & Announcements

Ajanta Pharma to announce Quarterly Result
20 hours ago

Ajanta Pharma to announce Quarterly Result

22 - Jan - 2019 12:00 AM | 20 hours ago

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 30 January 2019, to consider and approve unaudited consolidated & standalone Financial Results of the Company for the third quarter ended 31st December 2018
Powered by Capital Market - Live News
Board of Ajanta Pharma recommends interim dividend
82 days ago

Board of Ajanta Pharma recommends interim dividend

01 - Nov - 2018 12:00 AM | 82 days ago

Ajanta Pharma announced that the Board of Directors of the Company at its meeting held on 31 October 2018, inter alia, have recommended the interim dividend of Rs 9 per equity Share (i.e. 450%) , subject to the approval of the shareholders.
Powered by Capital Market - Live News
Ajanta Pharma consolidated net profit declines 4.93% in the September 2018 quarter
83 days ago

Ajanta Pharma consolidated net profit declines 4.93% in the September 2018 quarter

31 - Oct - 2018 12:00 AM | 83 days ago

Net profit of Ajanta Pharma declined 4.93% to Rs 125.39 crore in the quarter ended September 2018 as against Rs 131.89 crore during the previous quarter ended September 2017. Sales rose 0.69% to Rs 544.11 crore in the quarter ended September 2018 as against Rs 540.38 crore during the previous quarter ended September 2017.
Particulars Quarter Ended
Sep. 2018 Sep. 2017 % Var.
Sales 544.11 540.38 1
OPM % 30.55 34.00 -
PBDT 181.33 192.82 -6
PBT 163.84 178.27 -8
NP 125.39 131.89 -5
Powered by Capital Market - Live News
Ajanta Pharma standalone net profit declines 3.34% in the September 2018 quarter
83 days ago

Ajanta Pharma standalone net profit declines 3.34% in the September 2018 quarter

31 - Oct - 2018 12:00 AM | 83 days ago

Net profit of Ajanta Pharma declined 3.34% to Rs 104.10 crore in the quarter ended September 2018 as against Rs 107.70 crore during the previous quarter ended September 2017. Sales declined 0.82% to Rs 465.29 crore in the quarter ended September 2018 as against Rs 469.14 crore during the previous quarter ended September 2017.
Particulars Quarter Ended
Sep. 2018 Sep. 2017 % Var.
Sales 465.29 469.14 -1
OPM % 30.51 33.56 -
PBDT 158.84 165.32 -4
PBT 141.98 151.37 -6
NP 104.10 107.70 -3
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Ajanta Pharma Ltd has decreased by -7.22% since past 3 Months
MF shareholding in Ajanta Pharma Ltd has increased by 17.24% since past 3 Months
FII shareholding in Ajanta Pharma Ltd has decreased by -20.19% since past 1 Year
MF shareholding in Ajanta Pharma Ltd has increased by 57.47% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2018	Sep. 2017	% Var.
Sales	544.11	540.38	1
OPM %	30.55	34.00	-
PBDT	181.33	192.82	-6
PBT	163.84	178.27	-8
NP	125.39	131.89	-5

Particulars	Quarter Ended
	Sep. 2018	Sep. 2017	% Var.
Sales	465.29	469.14	-1
OPM %	30.51	33.56	-
PBDT	158.84	165.32	-4
PBT	141.98	151.37	-6
NP	104.10	107.70	-3

General Notifications

My Notifications

Research Notifications

Ajanta Pharma Ltd NSE / BSE Pharmaceuticals, Large Cap

1,162.70 19.45 (1.70%)

News & Announcements

Price vs Volume

Stock Trivia

Ajanta Pharma Ltd NSE / BSE
Pharmaceuticals, Large Cap

1,162.70

19.45 (1.70%)